Volume 9, Issue 1 (2021)                   Health Educ Health Promot 2021, 9(1): 49-54 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rabiei N, Gholami Fesharaki M, Rowzati M. Antihypertensive Medications in Hypertension Control in Male Industrial Employees: a Retrospective Cohort Study. Health Educ Health Promot 2021; 9 (1) :49-54
URL: http://hehp.modares.ac.ir/article-5-48809-en.html
1- Biostatistics Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Islamic Republic of Iran
2- Biostatistics Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Islamic Republic of Iran , mohammad.gholami@modares.ac.ir
3- Occupational Health Center, Mobarakeh Steel Company, Isfahan, Iran
Abstract:   (1555 Views)
Aims: Hypertension control is one of the most important healthcare issues in all societies. One way to control high blood pressure is to use antihypertensive medications. Therefore, this research was to study the effect of antihypertensive drugs on changing blood pressure, Body Mass Index, and Framingham Risk Score.
Instrument & Methods: This retrospective cohort study (from January 2014 to January 2018) was done on male workers who work in Mobarakeh steel company using the census method by referring to the workers' medical records. The case group (n=642) was hypertensive people who took medications for controlling hypertension, and the control group (n=1555) was healthy people without using any hypertension drug. The FRS is a gender-specific algorithm used to estimate the 10-year risk of cardiovascular in individuals. The blood pressure of both arms was measured by three general practitioners using a calibrated portable or wall-mounted Baumometer sphygmomanometer Kompak Model-260mmHg. Data were analyzed by independent t-test and multilevel modeling using R 3.2.1 software.
Findings: 2197 male workers participate. This study showed that changes in SBP, DBP, and FR's variables during 2014 to 2019 in the case group compared to the control group had a significant decrease (p<0.001). Nevertheless, this decrease was not significant for the BMI (p=0.588).
Conclusion: The use of antihypertensive drugs is a very effective method in controlling hypertension patients. Therefore, the priority of pharmacological method in the treatment of this patient is much more effective than other methods.
Full-Text [PDF 471 kb]   (833 Downloads) |   |   Full-Text (HTML)  (285 Views)  
Article Type: Original Research | Subject: Healthy Life Style
Received: 2020/12/1 | Accepted: 2021/02/2 | Published: 2021/05/10
* Corresponding Author Address: Tarbiat Modares University, Nasr Bridge, Jalal-Al-Ahmad Highway, Tehran, Iran. Postal Code: 1411713116

References
1. Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. [Link] [DOI:10.1186/s12933-018-0703-2] [PMID] [PMCID]
2. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. [Link] [DOI:10.1038/s41581-019-0244-2] [PMID] [PMCID]
3. World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009 [Link]
4. Hosseini M, Yaseri M, Asady H, Musa AE, Koohpayehzadeh J, Rafei A, et al. Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline. Med J Islam Repub Iran. 2019;33(1):151-7. [Link] [DOI:10.47176/mjiri.33.26]
5. Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: Prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204-10. [Link]
6. Katibeh M, Sanjari Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2020;26(3):301-11. [Link] [DOI:10.26719/emhj.19.042] [PMID]
7. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013;31(7):1281-357. [Link] [DOI:10.1097/01.hjh.0000431740.32696.cc] [PMID]
8. Laar AK, Adler AJ, Kotoh AM, Legido-Quigley H, Lange IL, Perel P, et al. Health system challenges to hypertension and related non-communicable diseases prevention and treatment: Perspectives from Ghanaian stakeholders. BMC Health Serv Res. 2019;19:693. [Link] [DOI:10.1186/s12913-019-4571-6] [PMID] [PMCID]
9. Maftoon F, Farzadi F, Aeenparast A, Montazeri A, Mohammad K, Pileroudi S, et al. Evaluation of National Program on Prevention and Control of Hypertension: The Study Protocol. Adv Biores. 2016;7(3):15-20. [Link]
10. Lee HY, Shin J, Kim GH, Park S, Ihm SH, Kim HC, et al. 2018 Korean society of hypertension guidelines for the management of hypertension: Part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20. [Link] [DOI:10.1186/s40885-019-0124-x] [PMID] [PMCID]
11. Dhar L, Dantas J, Ali M. A systematic review of factors influencing medication adherence to hypertension treatment in developing countries. Open J Epidemiol. 2017;7(3):211-50. [Link] [DOI:10.4236/ojepi.2017.73018]
12. Baghianimoghadam M, Aivazi S, Mzloomy SS, Baghianimoghadam B. Factors in relation with self-regulation of hypertension, based on the model of goal directed behavior in Yazd city. J Med Life. 2011;4(1):30-5. [Link]
13. Li G, Hu R, Zhang X. Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension. Hypertens Res. 2020;1-3. [Link] [DOI:10.1038/s41440-020-0433-1] [PMID] [PMCID]
14. Klarenbach SW, McAlister FA, Johansen H, Tu K, Hazel M, Walker R, et al. Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. Can J Cardiol. 2010;26(5):e158-63. [Link] [DOI:10.1016/S0828-282X(10)70383-4]
15. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. [Link] [DOI:10.1001/jama.2013.284427] [PMID]
16. Fattahi F, Kashkouli Behrouzi M, Zarrati M. Relation of body mass index, abdominal obesity, some nutritional habits and hypertension in 25-65 year old population of Tehran. KOOMESH. 2011;12(39):229-35. [Persian] [Link]
17. Gholami Fesharaki M, Rozati M, Tanhai AH. The longitudinal study of the relationship between work shift and blood pressure in workers of Mobarakeh Steel Company of Isfahan in 2007-2009. J Arak Uni Med Sci. 2011;13(4):68-74. [Persian] [Link]
18. Golabadi M, Dehghan F, Safakhah F, Attarchi MS. Assessment of effect of shift work on blood pressure in workers of a rubber manufacturing company. Razi J Med Sci. 2012;18(91):7-14. [Persian] [Link]
19. Rahimpour F, Jarahi L, Rafeemanesh E, Eghbali S. The effect of noise on blood pressure in the steel industry workers. Med J Mashhad Univ Med Sci. 2016;59(2):106-13. [Persian] [Link]
20. Bazyar F, Gholami-Fesharaki M, Rowzati M. The relationship between shift work and Framingham risk score: A five-year prospective cohort study. ARYA Atheroscler. 2017;13(6):288-94. [Link]
21. Khosravi A, Rowzati M, Gharipour M, Gholami Fesharaki M, Shirani Sh, Shahrokhi Sh, et al. Hypertension control in industrial employees: findings from SHIMSCO study. ARYA Atheroscler. 2012;7(4):191-6. [Link]
22. Echouffo-Tcheugui JB, Batty GD, Kivimäki M, Kengne AP. Risk models to predict hypertension: A systematic review. PLoS One. 2013;8(7):e67370. [Link] [DOI:10.1371/journal.pone.0067370] [PMID] [PMCID]
23. Gholami Fesharaki M, Kazemnejad A, Zayeri F, Sanati J, Akbari H. Historical cohort study on the factors affecting blood pressure in workers of polyacryl Iran corporation using bayesian multilevel modeling with skew T distribution. Iran Red Crescent Med J. 2013;15(5):418-23. [Link] [DOI:10.5812/ircmj.10930] [PMID] [PMCID]
24. Chia YC, Ching SM. Prevalence and predictors of resistant hypertension in a primary care setting: A cross-sectional study. BMC Fami Pract. 2014;15:131. [Link] [DOI:10.1186/1471-2296-15-131] [PMID] [PMCID]
25. Rezvan S, Besharati M, Khodadadpoor M, Matlabi M, Fathi A, Salimi A, et al. Self-care assessment of patients with hypertension in Qom city in 2016 (Iran). Qom Univ Med Sci J. 2018;12(4):72-80. [Persian] [Link] [DOI:10.29252/qums.12.4.72]
26. Newell M, Modeste N, Hopp Marshak H, Wilson C. Health beliefs and the prevention of hypertension in a black population living in London. Ethn Dis. 2009;19(1):35-41. [Link]
27. Fuladvandi M, Safarpour H, Malekyan L, Moayedi S, Askaryzadeh Mahani M, Salimi E. The survey of self-regulation behaviors and related factors in elderly with hypertension in the south-east of Iran. Sci Res. 2017;9(4):592. [Link] [DOI:10.4236/health.2017.94042]
28. Hazavehei MM, Dashti S, Moeini B, Faradmal J, Shahrabadi R, Yazdi AH. Factors related to self-care behaviors in hypertensive individuals based on Health Belief Model. KOOMESH. 2015;17(1):37-44. [Link]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.